Veracyte | VCYT - Le Bénéfice D'Exploitation

Prix De L'Action
32.29
Variation Quotidienne
1.20 3.86%
Mensuellement
-1.91%
Annuel
0.47%
Q2 Prévisions
30.24




Le Bénéfice D'Exploitation Changement Date
Agenus USD 14.4M 19.26M 2025-12
Agilent USD 353M 90M 2025-12
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD 40.81M 3.3M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
Illumina USD 256M 6M 2025-12
Intrexon USD -60.84M 26.62M 2024-06
Karyopharm Therapeutics USD -17.84M 13.44M 2025-12
Laboratory Of America USD 382M 15.3M 2025-12
Ligand Pharmaceuticals USD 158.89M 149.17M 2025-09
Myriad Genetics USD -3M 20.3M 2025-12
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Roche Holding CHF 9.56B 3.8B 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Siemens EUR 2.57B 3M 2025-12
Sonic Healthcare AUD 435.76M 193.66M 2024-12
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Veracyte USD 24.63M 1.52M 2025-12
Waters USD 270.52M 78.4M 2025-12